Feb 4, 20211 min readBiopharma Daily Stock Updates - 02/04/21$XBI $162.77 +1%COVID:$DVAX +2% Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization $AGEN +18% Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19 PIPELINE:$ALDX +6% Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design FINANCIAL:$SIOX +2% Sio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle Therapeutics $EQ +17% Equillium Announces Pricing of $30 Million Registered Direct Offering $DRRX -15% DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock
$XBI $162.77 +1%COVID:$DVAX +2% Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization $AGEN +18% Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19 PIPELINE:$ALDX +6% Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design FINANCIAL:$SIOX +2% Sio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle Therapeutics $EQ +17% Equillium Announces Pricing of $30 Million Registered Direct Offering $DRRX -15% DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock
